Journal Logo

Simultaneous Sessions IV: Aggressive lymphomas - First line, combination therapy and real-life data

S1599 RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON-NORDIC LYMPHOMA GROUP PHASE III STUDY

Lugtenburg, P.1; Brown, P.2; van der Holt, B.3; D’Amore, F.4; Koene, H.5; de Jongh, E.6; Fijnheer, R.7; Loosveld, O.8; Böhmer, L.9; Pruijt, H.10; Verhoef, G.11; Hoogendoorn, M.12; Bilgin, Y.13; Nijland, M.14; Lam, K.15; de Keizer, B.16; de Jong, D.17; Zijlstra, J.18

Author Information
doi: 10.1097/01.HS9.0000564644.71009.e6
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.